ARTA
HAE icon

A.R.T. Advisors’s Haemonetics HAE Stock Holding History

A.R.T. Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8,289
Closed -$952K – 446
2019
Q4 		$952K Buy
+8,289
New +$1M 0.05% 581
2018
Q3 		– Sell
-4,000
Closed -$358K – 1514
2018
Q2 		$358K Sell
4,000
-43,100
-92% -$3.64M 0.01% 1041
2018
Q1 		$3.44M Buy
47,100
+17,800
+61% +$1.22M 0.14% 198
2017
Q4 		$1.7M Buy
29,300
+14,300
+95% +$753K 0.08% 424
2017
Q3 		$673K Buy
+15,000
New +$623K 0.03% 709
2016
Q2 		– Sell
-35,299
Closed -$1.23M – 1471
2016
Q1 		$1.23M Buy
35,299
+27,900
+377% +$901K 0.06% 492
2015
Q4 		$238K Sell
7,399
-421
-5% -$13.7K 0.01% 1154
2015
Q3 		$252K Buy
+7,820
New +$294K 0.01% 1092
2014
Q2 		– Sell
-31,191
Closed -$1.02M – 1384
2014
Q1 		$1.02M Buy
+31,191
New +$1.19M 0.05% 493
2013
Q4 		– Sell
-6,432
Closed -$256K – 1352
2013
Q3 		$256K Sell
6,432
-6,596
-51% -$277K 0.01% 1038
2013
Q2 		$538K Buy
+13,028
New +$527K 0.02% 843

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

A.R.T. Advisors's HAE Position: Q1 2020 in Review

A.R.T. Advisors sold out of Haemonetics (HAE) in Q1 2020, closing a stake of 8,289 shares — an estimated $952K sold.

A.R.T. Advisors first reported a position in HAE in Q2 2013 and held it in 11 quarters. The position peaked at $3.44M in Q1 2018. 269 funds tracked by Wall St. Rank hold HAE as of Q1 2020.

  • A.R.T. Advisors reported no remaining Haemonetics position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 8,289 Haemonetics shares in Q1 2020, an estimated $952K.
  • A.R.T. Advisors first reported a position in Haemonetics in Q2 2013 and held it in 11 quarters.
  • A.R.T. Advisors's Haemonetics position peaked at $3.44M in Q1 2018.
  • 269 funds tracked by Wall St. Rank held Haemonetics as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.